Testing effectiveness (Phase 2)Study completedNCT00006202What this trial is testingLutein for Age-Related Macular DegenerationWho this might be right forMacular Degeneration National Eye Institute (NEI) 45
Large-scale testing (Phase 3)Ended earlyNCT00619229What this trial is testingAlprostadil in Maculopathy Study (AIMS)Who this might be right forMacular Degeneration UCB Pharma 37
Not applicableStudy completedNCT01350323What this trial is testingAqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 NeovascularizationWho this might be right forAge-related Macular Degeneration University of Molise 33
Testing effectiveness (Phase 2)Study completedNCT01213082What this trial is testingProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)Who this might be right forExudative Age-related Macular Degeneration University of California, Davis 34
Post-approval studies (Phase 4)Study completedNCT05832996What this trial is testingCool vs Room-temperature Artificial TearsWho this might be right forDiabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)Central Retinal Vein Occlusion With Macular EdemaExudative Age-Related Macular Degeneration, Unspecified Eye+4 more University of Iowa 124
Not applicableStudy completedNCT02464956What this trial is testingProduction of iPSC Derived RPE Cells for Transplantation in AMDWho this might be right forAge Related Macular Degeneration (AMD) Moorfields Eye Hospital NHS Foundation Trust 3
Not applicableActive Not RecruitingNCT07390253What this trial is testingSwitch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular (Wet) Age-Related Macular Degeneration Vienna Institute for Research in Ocular Surgery 50
Not applicableEnded earlyNCT04468373What this trial is testingStudy of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular DegenerationWho this might be right forAge Related Macular Degeneration VisionCare, Inc. 9
Post-approval studies (Phase 4)Ended earlyNCT02002377What this trial is testingIntravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab InjectionsWho this might be right forAge Related Macular Degeneration Unity Health Toronto 23
Testing effectiveness (Phase 2)Study completedNCT05403749What this trial is testingLonger Interval of IVT IBI302 in Subjects With nAMDWho this might be right forNeovascular Age-related Macular Degeneration Innovent Biologics (Suzhou) Co. Ltd. 132
Large-scale testing (Phase 3)Study completedNCT02611778What this trial is testingEfficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration (AMD) Bioeq GmbH 712
Large-scale testing (Phase 3)UnknownNCT00559715What this trial is testingPrevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and RanibizumabWho this might be right forAge-Related Neovascular Macular Degeneration Klinikum Bremen-Mitte, gGmbH 366
Testing effectiveness (Phase 2)UnknownNCT02749734What this trial is testingClinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration DiseasesWho this might be right forMacular DegenerationStargardt's Macular Dystrophy Southwest Hospital, China 15
Large-scale testing (Phase 3)Active Not RecruitingNCT06491914What this trial is testingA Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)Who this might be right forNeovascular Age-Related Macular DegenerationDiabetic Macular Edema Regeneron Pharmaceuticals 1,118
Not applicableStudy completedNCT01528605What this trial is testingEffects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Peking University 168
Not applicableUnknownNCT04469140What this trial is testingNon Exudative AMD Imaged With SS-OCT- ExtensionWho this might be right forDry Macular Degeneration Boston Image Reading Center 450
Large-scale testing (Phase 3)Study completedNCT03668054What this trial is testingSafety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)Who this might be right forAge-Related Macular Degeneration Laboratorio Elea Phoenix S.A. 22
Large-scale testing (Phase 3)Study completedNCT04435366What this trial is testingSafety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)Who this might be right forGeographic AtrophyMacular Degeneration IVERIC bio, Inc. 448
Not applicableStudy completedNCT00527553What this trial is testingThe Effect of Eggs and Egg Products on Macular PigmentWho this might be right forAge-related Macular Degeneration Maastricht University Medical Center 100
Post-approval studies (Phase 4)Study completedNCT01775124What this trial is testingEfficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)Who this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 332